Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth

Clinical Endocrinology

Volumn 63, Issue 1, 2005, Pages 39-44

  Greenman, Yona ^a,b   Tordjman, K ^a   Osher, E ^a   Veshchevt, I ^a   Shenkerman, G ^a   Reider Groswasser, I I ^a   Segev, Y ^a   Ouaknine, G ^c   Stern, N ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR VOLUME;

ADENOMA; ADULT; AGED; BROMOCRIPTINE; COHORT STUDIES; DOPAMINE AGONISTS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PITUITARY NEOPLASMS; POSTOPERATIVE PERIOD; SURVIVAL ANALYSIS; THYROTROPIN-RELEASING HORMONE; TREATMENT OUTCOME;

EID: 22044448227     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02295.x     Document Type: Article

References (24)

1. Bradley, K.M., Adams, C.B.T., Potter, C.P.S., Wheeler, D.W., Anslow, P.J. & Burke, C.W. (1994) An audit of selected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clinical Endocrinology, 41, 655-659.
2. Turner, H.E., Stratton, I.M., Byrne, J.V., Adams, C.B.T. & Wass, J.A.H. (1999) Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clinical Endocrinology, 51, 281-284.
3. Greenman, Y., Ouaknine, G., Veshchev, I, Reider-Groswasser, I.I., Segev, Y. & Stern, N. (2003) Post-operative surveillance of clinically non-functioning pituitary macroadenomas: markers of tumor quiescence and regrowth. Clinical Endocrinology, 58, 763-769.
4. Greenman, Y. & Melmed, S. (1996) Diagnosis and medical management of nonfunctioning pituitary tumors. Annual Review of Medicine, 47, 95-106.
5. Shomali, M.E. & Katznelson, L. (2002) Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas. Pituitary, 5, 89-98.
6. Serri, O., Marchisio, A.M., Collu, R., Hardy, J. & Somma, M. (1984) Dopaminergic binding sites in human pituitary adenomas other than prolactinomas. Hormone Research, 19, 97-102.
7. Bevan, J.S. & Burke, C.W. (1986) Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine. Clinical Endocrinology, 25, 561-572.
8. Koga, M., Nakao, H., Arao, M., Sato, B., Noma, K., Morimoto, Y., Kishimoto, S., Mori, S. & Vozumi, T. (1987) Demonstration of specific dopamine receptors on human pituitary adenomas. Acta Endocrinologica, 114, 592-602.
9. Lamberts, S.W.J., Verleun, T., Oosterom, R., Hofland, L., Van Ginkel, L.A., Loeber, J.G., Van Vroonhoven, C.C.J., Stefanko, S.Z. & De Jong, EH. (1987) The effects of bromocriptine, thyrotropin-releasing hormone and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. Journal of Clinical Endocrinology and Metabolism, 64, 524-530.
10. Klibanski, A., Shupnik, M.A., Bikkal, H.A., Black, P., Kilman, B. & Zervas, N.T. (1988) Dopaminergic regulation of α-subunit secretion and messenger ribonucleic acid levels in α-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 65, 96-102.
11. D'Emden, M.C. & Harrison, L.C. (1986) Rapid improvement of visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas. Clinical Endocrinology, 25, 697-702.
12. Vance, M.L., Ridgway, E.C. & Thorner, M.O. (1985) Follicle-stimulating hormone and α-subunit secreting pituitary adenoma treated with bromocriptine. Journal of Clinical Endocrinology and Metabolism, 61, 580-584.
13. Grossman, A., Ross, R., Charlesworth, M., Adams, C.B.T., Wass, J.A.H., Doniach, I. & Besser, G.M. (1985) The effect of dopamine agonist therapy on large functionless pituitary tumors. Clinical Endocrinology, 22, 679-686.
14. Van Schaardenburg, D., Roefselma, F., van Seters, A.P. & Vielvoye, G.J. (1989) Bromocriptine therapy for non-functioning pituitary adenoma. Clinical Endocrinology, 30, 475-484.
15. Nobels, F.R.E., de Herder, W.W., van den Brink, W.M., Kwekkeboom, D.J., Hofland, L.J., Zuyderwijk, J., de Jong, F.H. & Lamberts, S.W.J. (2000) Long term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma. European Journal of Endocrinology, 143, 615-621.
16. Colao, A., Ferone, D., Lastoria, S., Cerbone, G., Di Sarno, A., Di Somma, C., Lucci, R. & Lombardi, G. (2000) Hormone levels and tumor size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. Clinical Endocrinology, 52, 437-445.
17. Lohmann, T., Trantakis, C., Biesold, M., Prothmann, S., Guenzel, S., Schober, R. & Paschke, R. (2001) Minor tumour shrinkage in non-functioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline. Pituitary, 4, 173-178.
18. Pivonello, R., Matrone, C., Filippella, M., Cavallo, L.M., di Somma, C., Cappabianca, P., Annunziato, L. & Lombardi, G. (2004) Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. Journal of Clinical Endocrinology and Metabolism, 89, 1674-1683.
19. 2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 83, 1368-1375.
20. Lania, A., Reza-Elahi, F., Gil-del-Alamo, P., Saccomanno, K., Mantovani, S. & Spada, A. (1995) Abnormal transduction of dopamine signal in human nonfunctioning pituitary adenomas. Journal of Endocrinological Investigation, 18, 265-270.
21. Ouaknine, G., Razon, N., Avram, J., Veshchev, I., Rochkind, S., Ayalon, D., Reider-Groswasser, I., Jossipov, J., Stern, N., Greenman, Y. & Tordjman, K. (1997) Programmable classification of pituitary tumors. Proceedings of the 11th International Congress of Neurological Surgery, 547-550.
22. Somjen, D., Tordjman, K., Kohen, F., Baz, M., Razon, N., Ouaknine, G. & Stern, N. (1997) Combined βFSH and βLH response to TRH in patients with clinically non-functioning pituitary adenomas. Clinical Endocrinology, 46, 555-562.
23. Ebersold, M.J., Quast, L.M., Laws, E.R. Jr, Scheithauer, B. & Randall, R.V. (1986) Long term results in transsphenoidal removal of nonfunctioning pituitary adenomas. Journal of Neurosurgery, 69, 713-719.
24. Comtois, R., Beauregard, H., Somma, M., Serri, O., Aris-Jilwan, N. & Hardy, J. (1991) The clinical and endocrine outcome of transsphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer, 68, 860-866.